ctrl K

Price Alert

Orchestra BioMed Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

2.42

-0.01 (-0.41%)

At close: Sep 26, 2025, 3:59 PM

2.40

-0.83%

After-hours: Sep 26, 2025, 07:37 PM EDT

Orchestra BioMed Revenue Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024
Product Revenue	169K	136K	326K	184K	150K	123K
Product Revenue Growth	+24.26%	-58.28%	+77.17%	+22.67%	+21.95%	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Selling, General, and Administrative Revenue	6.26M	6.26M	5.9M	5.67M	6.47M	5.82M	4.15M	6.34M	5.32M	4.41M	876.72K	813.41K	2.95M	2.48M	92.05K	94.44K	96.32K	111.95K
Selling, General, and Administrative Revenue Growth	+0.02%	+6.13%	+4.15%	-12.39%	+11.06%	+40.35%	-34.60%	+19.29%	+20.56%	+403.12%	+7.78%	-72.39%	+18.89%	+2592.16%	-2.54%	-1.94%	-13.96%	n/a
Research and Development Revenue	13.85M	13.48M	10.97M	11.6M	11.13M	9.11M	8.51M	8.56M	8.5M	8.25M	7.54M	5.9M	5.03M	3.47M	3.53M	3.66M	2.64M	3.06M
Research and Development Revenue Growth	+2.75%	+22.89%	-5.38%	+4.22%	+22.10%	+7.06%	-0.55%	+0.69%	+2.97%	+9.43%	+27.87%	+17.30%	+44.76%	-1.61%	-3.50%	+38.76%	-13.91%	n/a

Ask AI